Redeye endorses the updated clinical guidelines in Japan supporting quantitative neuromuscular patie...
In May, Endomines unveiled its updated strategy for 2025–2029.
With additional funds and a streamlined organisation, Sprint Bioscience continues to proactively pro...
Redeye views Hunter Capital's purchase of shares and warrants from Heights Capital Management as ope...
This morning, Litium announced the acquisition of Geins, a SaaS e-commerce platform with strong AI a...
Acconeer has announced its A121 pulsed coherent radar has been selected by an additional Japanese ca...
Redeye is positive about the FDA clearance to expand the labeling of the Prism system.
Botnia Gold redovisade ett starkt andra kvartal med intäkter på 115 Mkr och ett rörelseresultat på 4...
Redeye initiates coverage of Senzime, a Swedish medtech company specialising in quantitative neuromu...
Ascelia has now submitted Orviglance to the FDA. The next step is to start the initial filing review...
Taaleri hosted its CMD today in Helsinki. The CMD offered a detailed description of Taaleri's strate...
Enrad AB:s nettoomsättning om 15,2 MSEK under kv2 2025 understeg vår prognos om 16,2 MSEK med ca 6%.
Återhämtningen i Q2 gick snabbare än väntat och nu väntar vi på de fulla effekterna av beredskapslok...
Redeye updates its estimates and fair value range following Dala Energi’s Q2 report that was release...
Redeye provides an update following Mindark’s Q2 2025 report.
